MED Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	670 225
Average Volume	463 085
Market Cap	281.52M
EPS	$0 ( 2024-04-29 )
Next earnings date	( $0.780 ) 2024-06-13
Last Dividend	$1.650 ( 2023-09-18 )
Next Dividend	$0 ( N/A )
P/E	4.16
ATR14	$0.0360 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Maloney James P.	Sell	73	Common Stock
2024-03-15	Maloney James P.	Sell	119	Common Stock
2024-03-15	Maloney James P.	Sell	424	Common Stock
2024-03-15	Mackenzie Jonathan Barrett	Sell	51	Common Stock
2024-03-15	Mackenzie Jonathan Barrett	Sell	83	Common Stock

INSIDER POWER
34.23
Last 99 transactions
Buy: 170 665 \| Sell: 85 180

Volume Correlation

Long: 0.16 (neutral)

Short: 0.34 (neutral)

Signal:(54.15) Neutral

Medifast Inc Correlation

10 Most Positive Correlations
HPP	0.952
NVRO	0.95
FUBO	0.95
BKKT	0.946
ACRE	0.945
IVOL	0.944
EXPR	0.944
INST	0.943
TBI	0.94
CMTG	0.939

10 Most Negative Correlations
SIXH	-0.964
BWNB	-0.961
BWSN	-0.959
BSX	-0.956
INCO	-0.955
SEDA	-0.955
DXJ	-0.954
PGR	-0.953
ETN	-0.95
MCY	-0.949

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Medifast Inc Correlation - Currency/Commodity

0.08
( neutral )

0.52
( weak )

0.00
( neutral )

0.06
( neutral )

0.03
( neutral )

Medifast Inc Financials

Annual	2023
Revenue:	$1.07B
Gross Profit:	$775.85M (72.37 %)
EPS:	$9.13

FY	2023
Revenue:	$1.07B
Gross Profit:	$775.85M (72.37 %)
EPS:	$9.13

FY	2022
Revenue:	$1.60B
Gross Profit:	$1.14B (71.34 %)
EPS:	$12.82

FY	2021
Revenue:	$1.53B
Gross Profit:	$1.13B (73.89 %)
EPS:	$14.01

Financial Reports:

No articles found.

Medifast Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$1.640 (N/A)	$1.640 (N/A)	$1.650 (N/A)	$1.650 (N/A)	$1.650 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Medifast Inc Dividend Information - Dividend King

Dividend Sustainability Score: 9.20 - good (92.03%) | Divividend Growth Potential Score: 6.02 - Stable (20.38%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.250	2015-12-23
Last Dividend	$1.650	2023-09-18
Next Dividend	$0	N/A
Payout Date	2023-11-07
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	$30.04	--
Avg. Dividend % Per Year	2.42%	--
Score	5.07	--
Div. Sustainability Score	9.20
Div.Growth Potential Score	6.02
Div. Directional Score	7.61	--

Next Divdend (Est)
(2024-07-01)

$1.688 Estimate 21.82 %

Dividend Stability

0.58 Average

Dividend Score

5.07

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2015	$0.250	0.78%
2016	$1.070	3.74%
2017	$1.440	3.43%
2018	$2.19	3.02%
2019	$3.38	2.67%
2020	$4.52	4.05%
2021	$5.68	2.95%
2022	$6.56	3.04%
2023	$4.95	4.30%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend King	2023-06-30	Quarterly	2	5.23%	8.53
ACP	Dividend Royal	2024-05-22	Monthly	14	11.88%	8.50
PVL	Dividend Royal	2023-11-15	Monthly	14	9.37%	8.50
ARR	Dividend Royal	2024-05-14	Monthly	15	11.08%	8.50
ACV	Dividend Royal	2024-06-13	Monthly	10	10.19%	8.50
AVK	Dividend Royal	2024-05-14	Monthly	22	9.54%	8.31
AFG	Dividend Royal	2024-04-12	Bi-Monthly	39	9.39%	8.06
JPT	Dividend King	2023-11-02	Monthly	8	4.19%	8.05
VCIF	Dividend Royal	2023-08-18	Monthly	6	8.05%	8.02
EDI	Dividend Royal	2023-12-07	Monthly	13	8.85%	7.94

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0755	1.500	8.49	10.00	[0 - 0.5]
returnOnAssetsTTM	0.224	1.200	2.54	3.05	[0 - 0.3]
returnOnEquityTTM	0.343	1.500	7.30	10.00	[0.1 - 1]
payoutRatioTTM	0.805	-1.000	1.948	-1.948	[0 - 1]
currentRatioTTM	2.84	0.800	0.776	0.621	[1 - 3]
quickRatioTTM	2.03	0.800	2.78	2.23	[0.8 - 2.5]
cashRatioTTM	1.263	1.500	4.10	6.14	[0.2 - 2]
debtRatioTTM	0.0679	-1.500	8.87	-10.00	[0 - 0.6]
interestCoverageTTM	29.74	1.000	0.0966	0.0966	[3 - 30]
operatingCashFlowPerShareTTM	8.33	2.00	7.22	10.00	[0 - 30]
freeCashFlowPerShareTTM	7.76	2.00	6.12	10.00	[0 - 20]
debtEquityRatioTTM	0.0975	-1.500	9.61	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.732	1.000	1.142	1.142	[0.2 - 0.8]
operatingProfitMarginTTM	0.0900	1.000	-0.199	-0.199	[0.1 - 0.6]
cashFlowToDebtRatioTTM	4.42	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	2.97	0.800	10.00	8.00	[0.5 - 2]
Total Score				9.20

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	4.14	1.000	9.68	0	[1 - 100]
returnOnEquityTTM	0.343	2.50	8.27	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	7.76	2.00	7.41	10.00	[0 - 30]
dividendYielPercentageTTM	12.82	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.33	2.00	7.22	10.00	[0 - 30]
payoutRatioTTM	0.805	1.500	1.948	-1.948	[0 - 1]
pegRatioTTM	0.262	1.500	-1.589	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.101	1.000	9.97	0	[0.1 - 0.5]
Total Score				6.02

Medifast Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Medifast Inc

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.